Pharmadrug Inc. (CSE:PHRX)

Canada flag Canada · Delayed Price · Currency is CAD
0.0100
-0.0050 (-33.33%)
Mar 21, 2025, 3:54 PM EST
-71.43%
Market Cap 1.62M
Revenue (ttm) n/a
Net Income (ttm) -13.17M
Shares Out 107.73M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 59,441
Average Volume 66,768
Open 0.0150
Previous Close 0.0150
Day's Range 0.0100 - 0.0150
52-Week Range 0.0050 - 0.0550
Beta 2.94
RSI 51.09
Earnings Date May 1, 2025

About Pharmadrug

Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally derived approved drugs. The company also engages in the researching and reformulating of established natural medicines; development of synthetic formulations of existing drugs for potential commercialization and distribution; development of cepharanthine, a drug for the treatment of infectious disease and rare cancers; and rese... [Read more]

Sector Healthcare
CEO Robert Steen
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PHRX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.